A5065266599- Thyroid Cancer Diagnosis and Treatment
- BRCA gene mutations in cancer
- Thyroid and Parathyroid Surgery
- Salivary Gland Tumors Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Radiology practices and education
- Ethics in Clinical Research
- Clinical Reasoning and Diagnostic Skills
- Head and Neck Surgical Oncology
- Global Cancer Incidence and Screening
- Innovations in Medical Education
- Voice and Speech Disorders
- Thyroid Disorders and Treatments
- Artificial Intelligence in Healthcare and Education
- Patient-Provider Communication in Healthcare
McGill University
2025
New York University
2024
NYU Langone Health
2023
University of California, Los Angeles
2023
Molecular testing has improved risk stratification and increased nonoperative management for patients with indeterminate thyroid nodules, but data on the long-term outcomes of current molecular tests Afirma Gene Sequencing Classifier (GSC) Thyroseq v3 are limited.To determine rate delayed operation false negative GSC in Bethesda III IV nodules.Prospective follow-up a single center, randomized, clinical trial comparing performance diagnosis nodules at University California, Los Angeles...
Clinical Thyroidology®Vol. 35, No. 12 Thyroid CancerRadio-Frequency Ablation for Low-Risk Cancer Results in Excellent Long-Term OutcomesRajam Raghunathan and Jesse D. PasternakRajam Section of Endocrine Surgery, Grossman School Medicine, New York University Langone Health, York, U.S.A.Search more papers by this author Pasternak Division General Toronto, Health Network, Ontario, Canada.Search authorPublished Online:13 Dec 2023AboutSectionsView articleView Full TextPDF/EPUB Permissions &...